Agios Pharm (AGIO) — Strategic Asset Allocation Index
Agios Pharm (AGIO) has a Strategic Asset Allocation Index of 33.8% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $347.25 Million) total $347.25 Million, measured against net assets of $1.03 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Agios Pharm's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Agios Pharm Strategic Asset Allocation Index (2011–2025)
This chart shows how Agios Pharm's Strategic Asset Allocation Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 33.8%, representing strategic assets of $347.25 Million against net assets of $1.03 Billion USD. For live market cap and overall valuation, see Agios Pharm market capitalisation.
Annual Strategic Asset Allocation Index for Agios Pharm (2011–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Agios Pharm from 2011 to 2025, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Agios Pharm (AGIO) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.0% | $310.01 Million | $- | $310.01 Million | $1.19 Billion | ▼ -15.4 pp |
| 2024 | 41.4% | $638.32 Million | $- | $638.32 Million | $1.54 Billion | ▲ +37.8 pp |
| 2023 | 3.6% | $29.43 Million | $- | $29.43 Million | $811.02 Million | ▼ -27.0 pp |
| 2022 | 30.6% | $336.86 Million | $22.99 Million | $313.87 Million | $1.10 Billion | ▲ +7.7 pp |
| 2021 | 22.9% | $295.30 Million | $28.92 Million | $266.38 Million | $1.29 Billion | ▼ -9.7 pp |
| 2020 | 32.5% | $129.90 Million | $32.29 Million | $97.61 Million | $399.50 Million | ▲ +3.7 pp |
| 2019 | 28.8% | $184.40 Million | $31.47 Million | $152.93 Million | $640.53 Million | ▼ -6.8 pp |
| 2018 | 35.6% | $244.44 Million | $24.32 Million | $220.12 Million | $687.54 Million | ▼ -9.3 pp |
| 2017 | 44.8% | $168.25 Million | $24.43 Million | $143.81 Million | $375.50 Million | ▲ +28.7 pp |
| 2016 | 16.1% | $57.59 Million | $25.34 Million | $32.25 Million | $358.59 Million | ▼ -7.7 pp |
| 2015 | 23.8% | $82.12 Million | $23.22 Million | $58.91 Million | $345.12 Million | ▼ -7.3 pp |
| 2014 | 31.1% | $131.77 Million | $6.39 Million | $125.38 Million | $424.37 Million | ▲ +7.6 pp |
| 2013 | 23.5% | $30.88 Million | $3.76 Million | $27.12 Million | $131.48 Million | ▲ +15.4 pp |
| 2012 | 8.1% | $3.56 Million | $3.56 Million | $- | $43.90 Million | ▲ +3.0 pp |
| 2011 | 5.1% | $3.22 Million | $3.22 Million | $- | $63.14 Million | — |